Introducing Embase AI: Revolutionizing Biomedical Research Access with AI Technology

Introduction to Embase AI


Elsevier has recently unveiled Embase AI, a groundbreaking enhancement to its comprehensive biomedical literature database, Embase. Launched on June 25, 2025, in London, this new functionality introduces generative AI capabilities designed to transform the way professionals access biomedical research.

The advent of Embase AI is a significant leap forward for various sectors including R&D, medical affairs, product development, academia, knowledge management, and education. The tool simplifies literature search processes while significantly improving decision-making and knowledge acquisition expectations by utilizing natural language queries.

Transforming Biomedical Research Access


With Embase AI, users will benefit from a powerful summarization feature that provides insights drawn from millions of biomedical publications, clinical trials, and conference abstracts. This innovative tool expands access to biomedical research by enhancing search capabilities irrespective of a user’s individual search proficiency. Consequently, the platform democratizes knowledge acquisition, allowing even novices to obtain critical insights. Users can quickly access summarized responses along with lists of key references, dramatically reducing research time and lowering the risk of missing important findings.

The foundation of Embase AI rests on the unparalleled Embase database, trusted by researchers worldwide for over 50 years. It offers real-time searches across the latest content, including peer-reviewed articles, clinical trials, preprints, and conference proceedings. To ensure transparency in search results, Embase AI employs a two-step ranking system that generates summaries with inline citations, reinforcing the credibility of the returned information. This advanced, daily-updated solution utilizes a hierarchy of medical concepts curated by specialists, ensuring that the precision and clarity of search results meet the highest standards.

Expert Insights and AI Development


Mirit Eldor, Managing Director of Life Sciences, stated, "Embase AI transforms how researchers and other users approach problem-solving, saving valuable time in seeking answers and encompassing key information while reducing the risk of omitting critical insights. Access to a reliable research tool is essential for all users, and our collaboration with scientists in academia, life sciences, and innovative industries will continually provide solutions that meet emerging needs. We understand that users demand trustworthy solutions, which is why we've built Embase AI with an emphasis on transparency, explainability, and accuracy.”

Developed in alignment with Elsevier’s Responsible AI Principles and Privacy Principles, Embase AI guarantees the highest level of data privacy and security. The utilization of third-party large language models (LLMs) is kept private, ensuring no information is stored or used for training public models. All data is securely preserved exclusively within Elsevier's protected private environment.

Webinar Announcement: Discover Embase AI


To coincide with the press release, Elsevier is hosting a free online seminar in Japan: the Embase AI Webinar. Scheduled for August 26, 2025, from 14:00 to 14:45 (JST), this event is designed to showcase the efficiencies that Embase AI brings to biomedical and pharmaceutical information searching.

Participants will learn how the integration of search functionalities and generative AI streamlines complex inquiries and accelerates information acquisition, allowing immediate access to the latest clinical trial data, drug side effect information, and research trends across diseases. The webinar will illustrate the practical applications of Embase AI, supplemented with case studies from the search functionalities.

About Elsevier


Elsevier is at the forefront of supporting advanced information and decision-making. For over a century, the organization has contributed to the progression of science and healthcare, assisting research communities, healthcare professionals, and educators across 170 countries. Their capability to facilitate knowledge accumulation and critical decision-making is rooted in the intersection of reliable, evidence-based scientific and medical content and advanced AI technologies. Furthermore, Elsevier is dedicated to fostering sustainability and inclusion in its corporate culture and product offerings, aligning with global partnerships in research and healthcare through the Elsevier Foundation.

For more details, visit elsevier.com or follow them on social media at @Elsevier Connect.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.